Try our mobile app

Published: 2022-01-28 11:39:22 ET
<<<  go to RDY company page
EX-99.2 3 drr0359_ex99-2.htm EXHIBIT 99.2

Exhibit 99.2

 

Dr. Reddy’s Laboratories Ltd.

8-2-337, Road No. 3, Banjara Hills,

Hyderabad - 500 034, Telangana,

India.

CIN : L85195TG1984PLC004507

 

Tel      : +91 40 4900 2900

Fax     : +91 40 4900 2999

Email : mail@drreddys.com

www.drreddys.com

 

January 28, 2022

 

The Secretary

National Stock Exchange of India Ltd.

BSE Ltd.

New York Stock Exchange Inc.

NSE IFSC Ltd.

 

Dear Sir/Madam,

 

Sub:     Allotment of Equity Shares on exercise of ESOP

 

This is to inform you that the Nomination, Governance and Compensation Committee of the Board of Directors of the Company has approved the allotment of 6,569 equity shares of Rs.5/- each of the Company, fully paid up, on January 27, 2022, to employees pursuant to exercise of their Stock Options as per the following details:

 

a)6,569 equity shares of Rs. 5/- each pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002.

 

Please find enclosed the details as required under Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

 

This is for your information and records.

 

With regards,

 

/s/ Vivek Mittal  
Vivek Mittal  
Global General Counsel and Compliance Officer  
Encl: as above  

 

   

 

 

 

Details under Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021

 

1 Company name and address of Registered Office:
Dr. Reddy's Laboratories Limited
8-2-337, Road No.3, Banjara Hills, Hyderabad – 500034
2

Name of the Stock Exchanges on which the company’s shares are listed:
BSE Limited
National Stock Exchange of India Limited
New York Stock Exchange Inc. (ADRs)

NSE IFSC Limited (ADRs)

3

Filing date of the statement referred in Regulation 10(b) of the SEBI (Share Based Employee Benefits) Regulations, 2021 with Stock Exchange:

The Schemes were institutionalised under the erstwhile SEBI (Employee Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999 and appropriate details under Schedule V were filed. The Schemes complies with provisions of SEBI (Share Based Employee Benefits) Regulation, 2021.

4 Filing Number, if any : NA
5 Title of the Scheme pursuant to which shares are issued, if any:
Dr. Reddy’s Employees Stock Options Scheme, 2002
6 Kind of security to be listed: Equity Shares
7 Par value of the shares: Rs. 5/-
8 Date of issue of shares: January 27, 2022 (Date of allotment on exercise)
9 Number of shares issued: 6,569 equity shares
10 Share Certificate No., if applicable: NA
11 Distinctive number of the share, if applicable : 171494397 to 171500965
12 ISIN Number of the shares if issued in Demat : INE089A01023
13

Exercise price per share:

a.       6,569 equity shares exercised at Rs. 5/- per share

14 Premium per share: NIL
15 Total Issued shares after this issue :  166,423,461 (*)
16 Total Issued share capital after this issue : Rs. 832,118,305/-
17 Details of any lock-in on the shares : NA
18 Date of expiry of lock-in:  NA
19 Whether shares identical in all respects to existing shares if not, when will they become identical?:
Yes, the shares rank pari passu with the existing shares
20 Details of listing fees, if payable : NA

 

(*)Total paid up capital after this issue: 166,423,461 i.e. Rs. 832,117,305 (difference of 200 due to forfeited shares of Rs. 5/- each in September 1988 due to non-payment of allotment money.)